Related Experiment Video
Updated: May 29, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Anti-cancer characteristics of mevinolin against three different solid tumor cell lines was not solely p53-dependent
Ali Mokhtar Mahmoud1, Ahmed M Al-Abd, David A Lightfoot
1Faculty of Agriculture Research Park (FARP) and Biochemistry Department, Faculty of Agriculture, Cairo University, Giza, Egypt.
Abstract:
Mevinolin (MVN) has been used clinically for the treatment of hypercholesterolemia with very good tolerance by patients. Based on epidemiological evidences, MVN was suggested strongly for the treatment of neoplasia. Early experimental trials suggested the mixed apoptotic/necrotic cell death pathway was activated in response to MVN exposure. Herein, the cytotoxic profile of MVN was evaluated, compared to the robust and frequently used anti-cancer drug doxorubicin (DOX), against breast (MCF-7), cervical (HeLa) and liver (HepG(2)) transformed cell lines. MVN was showed comparable results in cytotoxic profile with DOX in all tested solid tumor cell lines. In addition, the MVN-induced cytotoxicity was inferred to be multi-factorial and not solely dependent on p53 expression. It was concluded that molecular and genetic assessment of MVN-induced cell death would be useful for developing cancer therapeutic treatments.
Insights
Mevinolin (MVN), a cholesterol-lowering drug, shows potent anti-cancer effects comparable to doxorubicin (DOX) against solid tumors. Its cytotoxicity is multi-factorial, offering promise for novel cancer therapies.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Mevinolin (MVN) is clinically used for hypercholesterolemia with good patient tolerance.
- Epidemiological data suggest MVN's potential in cancer treatment.
- Previous studies indicated MVN activates a mixed apoptotic/necrotic cell death pathway.
Purpose of the Study:
- To evaluate the cytotoxic profile of Mevinolin (MVN).
- To compare MVN's efficacy against breast, cervical, and liver cancer cell lines with doxorubicin (DOX).
- To investigate the mechanisms of MVN-induced cytotoxicity.
Main Methods:
- Cytotoxicity assays were performed on MCF-7 (breast), HeLa (cervical), and HepG(2) (liver) cancer cell lines.
- Mevinolin (MVN) and doxorubicin (DOX) were used as treatment agents.
- The role of p53 expression in MVN-induced cell death was assessed.
Main Results:
- Mevinolin (MVN) demonstrated a cytotoxic profile comparable to doxorubicin (DOX) across all tested solid tumor cell lines.
- MVN-induced cytotoxicity was found to be multi-factorial.
- Cytotoxicity was not solely dependent on p53 expression.
Conclusions:
- Mevinolin (MVN) exhibits significant anti-cancer potential against solid tumors.
- The multi-factorial nature of MVN's cytotoxicity warrants further investigation.
- Molecular and genetic assessment of MVN-induced cell death could inform future cancer therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

